Search Medical Condition
Please enter condition
Please choose location

Gaithersburg, Maryland Clinical Trials

A listing of Gaithersburg, Maryland clinical trials actively recruiting patient volunteers.

RESULTS

Found (101) clinical trials

Vortioxetine 5 10 and 20 mg Relapse Prevention Study in Adults With Major Depressive Disorder

The drug being tested in this study is called vortioxetine. Vortioxetine is being tested for the prevention of relapse in adults with major depressive disorder (MDD) who respond to daily treatment with vortioxetine. This study will look at relapse rates of MDD in people who take vortioxetine. The study will ...

Phase

0.0 miles

Learn More »

A Study to Evaluate the Effects of Basmisanil in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS) Treated With Antipsychotics

This multicenter study will assess the effects of 24 weeks of basmisanil treatment on cognition and functioning of stable CIAS participants treated with antipsychotics.

Phase

0.0 miles

Learn More »

A Study of the Efficacy and Safety of Intranasal Esketamine in the Rapid Reduction of Symptoms of Major Depressive Disorder in Adults at Imminent Risk for Suicide

This is a randomized (study medication assigned to participants by chance), double-blind (neither the researchers nor the participants know what treatment the participant is receiving), placebo-controlled (an inactive substance which contains no drug) that is compared in a clinical trial with a drug to test if the drug has a ...

Phase

0.0 miles

Learn More »

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)

This will be a randomized, placebo-controlled, parallel-group, multi-site, double-blind trial of MK-8189 compared with placebo, using Risperidone as an active control. The participants will be adult subjects experiencing an acute episode of schizophrenia, according to the criteria specified in the Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5). ...

Phase

0.0 miles

Learn More »

Are you struggling with depressive symptoms? In this clinical trial, patients with depression will be given a standard antidepressant therapy for an 8-week period. At the end of this initial treatment phase, patients will receive an additional medication (either the study drug or placebo). Patients who enter the study and ...

Phase

0.0 miles

Learn More »

Comparative Effectiveness of Cardiovascular Outcomes in New Users of SGLT-2 Inhibitors

In September 2015 the EMPA-REG trial presented data on positive effects of empagliflozin, a SGLT-2 inhibitor on cardiovascular (CV) outcomes. This has created a need for data on how this class of medicines affect CV event rates when used in clinical practice. The primary aim of this observational study is ...

Phase N/A

0.67 miles

Learn More »

Evaluating the Physical and Psychological Effects of Cancer Treatment in Patients With Breast Cancer

OBJECTIVES: - Determine the frequency and severity of symptom distress, pathological conditions, physical impairments, functional limitations, and disabilities during the course of medical treatment. - Strengthen the morbidity risk factor model developed in a previous retrospective study. OUTLINE: This is a multicenter study. Information about demographics; past medical history; family ...

Phase N/A

1.01 miles

Learn More »

Spinal Cord Injury Registry - NACTN

The participating centers include: University of Texas Health Science Center, Houston University of Toronto, Toronto University of Virginia, Charlottesville University of Louisville, Louisville University of Maryland, Baltimore Walter Reed National Military Medical Center, Bethesda, MD Thomas Jefferson University,Philadelphia University of Miami, Miami Brooke Army Medical Center, Fort Sam Houston; Louisiana ...

Phase N/A

1.01 miles

Learn More »

RRx-001 in Small Non-small Cell Lung Cancer Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

This is an open label, four-arm, three stage, pilot study for co-administration of RRx-001 with autologous blood once weekly until progression followed by reintroduction of platinum-based doublet therapy. The study is designed to explore the potential of the epigenetic agent RRx-001 to sensitize patients who previously responded and now have ...

Phase

1.01 miles

Learn More »

AZD9291 Versus Placebo in Patients With Stage IB-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection With or Without Adjuvant Chemotherapy.

This is a phase 3 double-blind, randomized, placebo-controlled, study to assess the efficacy and safety of AZD9291 versus placebo in patients with stage IB-IIIA non-small cell lung cancer (NSCLC) with centrally confirmed, most common sensitising EGFR mutations (Ex19Del and L858R) either alone or in combination with other EGFR mutations as ...

Phase

1.01 miles

Learn More »